Free provider profile

MANDI BATTLES, PA-C

NPI 1538398870
Individual
Physician Assistant, Medical
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MANDI BATTLES?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MANDI BATTLES prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Dupixent Pen
  • Skyrizi Pen
  • Bimzelx Autoinjector
  • Tremfya
  • Cosentyx Unoready Pen

See all physician assistants in CA who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

707-444-1331

Fax

707-444-1369

Practice address

525 2ND ST STE 203, EUREKA, CA, 95501

Registry updated
2026-09-02
NPI issued
2009-07-08
RepVector retrieved
11/21/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

525 2ND ST STE 203, EUREKA, CA, 95501

707-444-1331

Single practice location

Enumerated 2009-07-08

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record updated within the last year.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,581

Medicare patients

557

Part D drug cost

$2,665,957

Brand-name share

Not published

of this prescriber's Part D claims

DrugClaimsMedicare cost
Skyrizi Pen (Risankizumab-Rzaa)32$664,276
Dupixent Pen (Dupilumab)96$362,056
Bimzelx Autoinjector (Bimekizumab-Bkzx)24$347,058
Tremfya (Guselkumab)24$322,934
Cosentyx Unoready Pen (Secukinumab)17$129,120
Rinvoq (Upadacitinib)13$120,224
Adbry (Tralokinumab-Ldrm)16$77,721
Sotyktu (Deucravacitinib)11$73,254

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across CA — which companies pay providers there.

Open Payments page for this provider

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.